105 related articles for article (PubMed ID: 6681765)
1. Validation of the SCM-test for the diagnosis of cancer.
Deutsch M; Weinreb A
Eur J Cancer Clin Oncol; 1983 Feb; 19(2):187-93. PubMed ID: 6681765
[TBL] [Abstract][Full Text] [Related]
2. [Clinical significance of polarizing luminescence in the study of changes in the cytoplasm of lymphocytes--SCM test].
Benes J
Sb Lek; 1984 Sep; 86(8-9):245-50. PubMed ID: 6209784
[No Abstract] [Full Text] [Related]
3. Tumour specificity of the SCM test for cancer diagnosis.
Chaitchik S; Asher O; Deutsch M; Weinreb A
Eur J Cancer Clin Oncol; 1985 Oct; 21(10):1165-70. PubMed ID: 2416568
[TBL] [Abstract][Full Text] [Related]
4. The SCM test for cancer. an evaluation in terms of lymphocytes from healthy donors and cancer patients.
Mitchell H; Wood P; Pentycross CR; Abel E; Bagshawe KD
Br J Cancer; 1980 May; 41(5):772-7. PubMed ID: 6158967
[TBL] [Abstract][Full Text] [Related]
5. Lymphocyte fluorescence polarization measurements with the cellscan system: application to the SCM cancer test.
Deutsch M; Ron I; Weinreb A; Tirosh R; Chaitchik S
Cytometry; 1996 Feb; 23(2):159-65. PubMed ID: 8742175
[TBL] [Abstract][Full Text] [Related]
6. An analysis of the SCM test in cancer diagnosis.
Atkinson RJ; Lowry WS; Strain P
Cancer; 1983 Jul; 52(1):91-100. PubMed ID: 6342753
[TBL] [Abstract][Full Text] [Related]
7. Lymphocyte response to antigen stimulation as measured by fluorescence polarization (SCM test).
Pritchard JA; Sutherland WH
Br J Cancer; 1978 Aug; 38(2):339-43. PubMed ID: 698051
[No Abstract] [Full Text] [Related]
8. [Studies on fluorescence polarization of human blood lymphocytes (SCM test) using a Percoll gradient centrifugal separation method].
Tenzaki T; Matsumoto J; Ishiguro T; Yoshida Y; Sugiyama S
Rinsho Byori; 1984 Apr; 32(4):394-8. PubMed ID: 6088848
[No Abstract] [Full Text] [Related]
9. Evaluation of fluorescence polarization of human blood lymphocytes (SCM test) in the diagnosis of cancer.
Schnuda ND
Cancer; 1980 Sep; 46(5):1164-73. PubMed ID: 7214300
[TBL] [Abstract][Full Text] [Related]
10. Response of human lymphocytes to PHA and tumour-associated antigens as detected by fluorescence polarization.
Balding P; Light PA; Preece AW
Br J Cancer; 1980 Jan; 41(1):73-85. PubMed ID: 6153900
[TBL] [Abstract][Full Text] [Related]
11. Measurement of cytoplasmic viscosity by fluorescence polarization in phytohemagglutinin-stimulated and unstimulated human peripheral lymphocytes.
Hashimoto Y; Shinozaki N
J Histochem Cytochem; 1988 Jun; 36(6):609-13. PubMed ID: 3367046
[TBL] [Abstract][Full Text] [Related]
12. Response of T lymphocytes to phytohaemagglutinin (PHA) and to cancer-tissue-associated antigens, measured by the intracellular fluorescence polarization technique (SCM test).
Orjasaeter H; Jordfald G; Svendsen I
Br J Cancer; 1979 Oct; 40(4):628-33. PubMed ID: 387060
[TBL] [Abstract][Full Text] [Related]
13. [Response of human lymphocytes to phytohemagglutinin (PHA) as measured by fluorescence polarization technique--differences between malignant conditions and benign or healthy conditions].
Tenzaki T; Ishiguro T
Nihon Gan Chiryo Gakkai Shi; 1989 Apr; 24(4):817-25. PubMed ID: 2778375
[TBL] [Abstract][Full Text] [Related]
14. Lymphocyte fluorescence polarization changes after phytohemagglutinin stimulation in the diagnosis of colorectal carcinoma.
Hocking GR; Rolland JM; Nairn RC; Pihl E; Cuthbertson AM; Hughes ES; Johnson WR
J Natl Cancer Inst; 1982 Apr; 68(4):579-83. PubMed ID: 6951073
[TBL] [Abstract][Full Text] [Related]
15. A clinical assessment of fluorescence polarisation changes in lymphocytes stimulated by phytohaemagglutinin (PHA) in malignant and benign diseases.
Pritchard JA; Sutherland WH; Siddall JE; Bater AJ; Kerby IJ; Deeley TJ; Griffith G; Sinclair R; Davies BH; Rimmer A; Webster DJ
Eur J Cancer Clin Oncol; 1982 Jul; 18(7):651-9. PubMed ID: 6751831
[TBL] [Abstract][Full Text] [Related]
16. Changes in structuredness of cytoplasmic matrix in single stimulated lymphocytes from healthy donors and patients with non-malignant and malignant diseases.
Hashimoto Y; Takaku F; Yamanaka T
Br J Cancer; 1979 Jul; 40(1):156-60. PubMed ID: 454560
[No Abstract] [Full Text] [Related]
17. A flow system adaptation of the SCM test for detection of lymphocyte response in patients with recurrent breast cancer.
Stewart S; Pritchard KI; Meakin JW; Price GB
Clin Immunol Immunopathol; 1979 Jun; 13(2):171-81. PubMed ID: 156612
[No Abstract] [Full Text] [Related]
18. Changes in SCM-responses of lymphocytes in mice after implantation with Ehrlich ascites cells.
Cercek L; Cercek B
Eur J Cancer (1965); 1981 Feb; 17(2):167-71. PubMed ID: 7262153
[No Abstract] [Full Text] [Related]
19. Identification of mitogen responding lymphocytes by fluorescence polarization.
Udkoff R; Chan S; Norman A
Cytometry; 1981 Jan; 1(4):265-71. PubMed ID: 7021109
[TBL] [Abstract][Full Text] [Related]
20. An analysis of the SCM test in cancer diagnosis.
Cercek B
Cancer; 1984 Jun; 53(12):17A-18A. PubMed ID: 6722719
[No Abstract] [Full Text] [Related]
[Next] [New Search]
